AIM ImmunoTech Inc (AIM) Annual Income Statement (USD)
AIM Quarterly Financials (USD)
Frequently Asked Questions About AIM ImmunoTech Inc (AIM) Stock
AIM ImmunoTech Inc's (AIM) last reported annual revenue was USD 202000.00.
AIM ImmunoTech Inc's (AIM) annual revenue growth rate based on the revenue reported in the past 5 years is : 7.45%
AIM ImmunoTech Inc's(AIM) is not profitable as of its last reported annual financials.
The net profit margin for AIM ImmunoTech Inc's(AIM) from its laster reported year is -14337.62%
The return on equity (ROE) for AIM ImmunoTech Inc's(AIM) from its last reported annual financials is : -187.58%
The return on assets (ROA) for AIM ImmunoTech Inc's(AIM) from its last reported annual financials is : -84.20%
The return on invested capital (ROIC) for AIM ImmunoTech Inc's(AIM) from its last reported annual financials is : -131.07%
The Debt to Equity ratio for AIM ImmunoTech Inc's(AIM) from its last reported annual financials is : 0.00%
The dividend yield for AIM ImmunoTech Inc's(AIM) from its laster reported year is 0.00%
AIM ImmunoTech Inc's(AIM) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AIM !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
